Taxotere Lawsuit Information
According to the Taxotere prescribing information, “Loss of hair occurs in most patients taking Taxotere (including the hair on your head, underarm hair, pubic hair, eyebrows, and eyelashes). Hair loss will begin after the first few treatments and varies from patient to patient. Once you have completed all your treatments, hair generally grows back.” While hair loss is a small price to pay for the treatment of cancer, permanent hair loss from Taxotere may be avoided if patients choose a different chemotherapy drug that isn’t associated with persistent or permanent baldness. Patients who underwent chemotherapy treatment with Taxotere and have since experienced permanent hair loss may be eligible for compensation, which they can pursue by filing a Taxotere injury lawsuit against Sanofi-Aventis.
Estimates indicate that there are about 2.8 million women in the United States with a history of breast cancer, and of these, approximately 75% were prescribed Taxotere as a treatment for their symptoms. Unfortunately, many of these women were unaware of the potential link between Taxotere and permanent hair loss side effects when they were prescribed the drug, which means they were deprived of the option to choose another chemotherapy medication that is not linked to permanent baldness.
If you took the chemotherapy treatment Taxotere, and you have since experienced permanent hair loss, contact a knowledgeable product liability lawyer today to discuss your legal options.